Role
The Advisory Group consists of clinical professionals from this area of medicine. The advisory group will make recommendations to the Jurisdictional Haemopoietic Progenitor Cell Committee (JHPCC) on future HPC sector reform proposed within the framework.
The first topic the advisory group will consider is how new HPC donors are recruited in Australia.
For more information on the roles and responsibilities of the advisory group, see the HPC Sector Clinical Advisory Group Governance resource.
Haemopoietic Progenitor Cell Sector Clinical Advisory Group Governance
Members
We appoint members for their expertise in clinical haematology, tissue typing, laboratory accreditation and regulatory frameworks.
|
Member |
Role / Expertise |
Position |
|
Dr Neil Everest, (Chair) |
Clinical & public health; medicines & biologicals regulation; health technology assessment & reimbursement |
Senior Medical Adviser, Technology Assessment and Access Division, Department of Health and Aged Care |
|
Prof Robert Carroll |
Clinical Nephrologist & Tissue Typing Specialist |
Senior Nephrologist, South Australia Health, SA Immunogenetics Laboratory Manager, Lifeblood Australian Red Cross Blood Service |
|
Ms Natalie Clark Reynolds |
Consumer representative |
Consumer representative |
|
Ms Wendy Harris |
NATA representative |
Lead Accreditation Specialist, National Association of Testing Authorities (NATA) Australia |
|
A/Prof Anna Johnston |
Clinical Haematologist and Transplant Physician |
Head of Clinical Haematology and Bone Marrow Transplant, Royal Hobart Hospital, TAS Director, State-wide Bone Marrow Transplant Service, TAS |
|
Prof Ian Kerridge |
Clinical Haematologist, Transplant Physician and Bioethicist |
Staff Haematologist and Bone Marrow Transplant Physician, Royal North Shore Hospital, NSW Prof of Bioethics and Medicine, University of Sydney, NSW |
|
Ms Fiona McCormack |
TGA representative |
Director, In Vitro Diagnostics Medical Device (IVD) Team, Medical Devices Authorisation Branch, Therapeutic Goods Administration, Department of Health and Aged Care |
|
Dr Richard Mitchell |
Clinical Haematologist and Oncologist, Paediatric Transplant Physician |
Acting Director, Kids Cancer Centre, Sydney Children’s Hospital, NSW Director of Transplant & Cellular Therapies Unit, Kids Cancer Centre, Sydney Children’s Hospital, NSW |
|
Dr Duncan Purtill |
Clinical Haematologist and Transplant Physician |
Clinical Haematologist and Director of the Bone Marrow Transplant Program, Fiona Stanley Hospital, WA Medical Director, Bone Marrow Transplant Laboratory, PathWest Laboratory Medicine, WA |
|
Dr Beverley Rowbotham |
Clinical Haematologist and Accreditation Specialist |
Consultant Haematologist, Sullivan Nicolaides Pathology, QLD Chair, National Pathology Accreditation Advisory Council, Department of Health and Aged Care |
|
Prof Erica Wood |
Clinical Haematologist |
Consultant Haematologist, Monash Health, VIC Prof and Head, Transfusion Research Unit, Monash University, VIC |
|
A/Prof David Yeung |
Clinical Haematologist and Transplant Physician |
Head of Haematology, Royal Adelaide and The Queen Elizabeth Hospitals, SA Consultant Haematologist, Royal Adelaide Hospital and South Australia Pathology, SA |
If the Advisory Group requires other expertise, we will invite more clinical and non-clinical experts to participate.
Meetings
The HPC Sector Clinical Advisory Group will meet at least four times per year.
Contact
